CCO Oncology Podcast

185 Odcinki

1. Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

   Opublikowany: 17.02.2023
2. Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

   Opublikowany: 17.02.2023
3. Individualizing Care for Patients With Triple-Negative Breast Cancer

   Opublikowany: 18.01.2023
4. Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

   Opublikowany: 11.01.2023
5. HCC Surveillance: Challenges and Opportunities

   Opublikowany: 3.01.2023
6. A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer

   Opublikowany: 13.12.2022
7. The Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System

   Opublikowany: 29.11.2022
8. Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers

   Opublikowany: 29.11.2022
9. Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions

   Opublikowany: 9.11.2022
10. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

    Opublikowany: 28.10.2022
11. Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

    Opublikowany: 24.10.2022
12. Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting

    Opublikowany: 24.10.2022
13. Expert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer

    Opublikowany: 4.10.2022
14. Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions

    Opublikowany: 28.09.2022
15. New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022

    Opublikowany: 30.08.2022
16. Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management

    Opublikowany: 22.08.2022
17. HER2-Positive Breast Cancer: Current Approaches for Quality Care

    Opublikowany: 28.07.2022
18. New Evidence With BTK Inhibitor Therapy in CLL and MCL From EHA 2022

    Opublikowany: 21.07.2022
19. New Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022

    Opublikowany: 6.07.2022
20. Expert Insights on New Data From ASCO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

    Opublikowany: 30.06.2022